OptiNose Inc
NASDAQ:OPTN
OptiNose Inc
Revenue
OptiNose Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
OptiNose Inc
NASDAQ:OPTN
|
Revenue
$71m
|
CAGR 3-Years
13%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$85.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$45.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$55.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$61.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$35.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
OptiNose Inc
Revenue Breakdown
Breakdown by Geography
OptiNose Inc
Breakdown by Segments
OptiNose Inc
Total Revenue:
71m
USD
|
Net Product Revenues:
71m
USD
|
See Also
What is OptiNose Inc's Revenue?
Revenue
71m
USD
Based on the financial report for Dec 31, 2023, OptiNose Inc's Revenue amounts to 71m USD.
What is OptiNose Inc's Revenue growth rate?
Revenue CAGR 5Y
59%
Over the last year, the Revenue growth was -7%. The average annual Revenue growth rates for OptiNose Inc have been 13% over the past three years , 59% over the past five years .